Get started
Author

Jenna Brown

Observed name: Brown, Jenna
ORCID: 0000-0002-7789-4175
Observed ORCID: 0000-0002-7789-4175
OpenAlex ID: A5013101151
Silent cerebral infarction during immune TTP remission - prevalence, predictors, and impact on cognition
2023 · Shruti Chaturvedi, Jia Yu, et al. · Blood · 27
PDF
Silent Cerebral Infarction during Immune TTP Remission - Prevalence, Predictors and Impact on Cognition
2022 · Jia Yu, Jenna Brown, et al. · Blood · 15
Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura
2022 · Jenna Brown, Bindu Potugari, et al. · Annals of Hematology · 14
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era
2024 · Ayotola Fatola, Michael D. Evans, et al. · Blood Advances · 5
Progressive silent cerebral infarction is associated with stroke and persistent cognitive impairment in survivors of iTTP
2025 · Jia Yu, Jenna Brown, et al. · Blood Advances · 3
PDF
Risk factors for silent cerebral infarction in immune‐mediated thrombotic thrombocytopenic survivors
2025 · Binish Javed, Jia Yu, et al. · British Journal of Haematology · 2
PDF
Unmet health care needs in immune thrombotic thrombocytopenic purpura survivors
2026 · Charlotte M. Story, Jenna Brown, et al. · Research and Practice in Thrombosis and Haemostasis · 1
PDF
VWF:ADAMTS13 ratio is associated with white matter hyperintensity
2025 · Charlotte Story, Lisa Yanek, et al. · Blood · 1
Standard cardiovascular risk prediction scores underestimate risk in immune-mediated thrombotic thrombocytopenic purpura survivors
2025 · Binish Javed, Jenna Brown, et al. · Research and Practice in Thrombosis and Haemostasis · 1
PDF
Patient Reported Outcomes during Long-Term Follow-up of Atypical Hemolytic Uremic Syndrome in the Era of Terminal Complement Inhibition
2024 · Anne K Hubben, Jenna Brown, et al. · Blood · 1
PDF
Silent Cerebral Infarction Is Progressive during Clinical Remission and Associated with Stroke in Immune TTP Survivors
2024 · Shruti Chaturvedi, Jenna Brown, et al. · Blood · 1
PDF
Idiopathic multicentric Castleman disease - TAFRO results in high levels of mTOR activator SVEP1, tissue factor, and endotheliopathy
2024 · Chen Lossos, Jenna Brown, et al. · Blood Vessels Thrombosis & Hemostasis · 1
Unmet Needs of Immune Thrombotic Thrombocytopenic Purpura (iTTP)-Specific Pregnancy Counseling, Care and Outcomes in Women with Ittp
2023 · Jenna Brown, Shruti Chaturvedi, et al. · Blood · 1
PDF
Idiopathic Multicentric Castleman Disease Results in Endothelium Activation and Coagulation Dysregulation Via Tissue Factor and PAI-1
2023 · Chen Lossos, Jenna Brown, et al. · Blood · 1
Increased VWF-to-ADAMTS13 ratio is associated with large cerebral white matter hyperintensities
2026 · Charlotte M. Story, Lisa Yanek, et al. · Blood Vessels Thrombosis & Hemostasis
The Patient-Reported Outcomes Measurement Information System perspective of adults with long-standing atypical hemolytic uremic syndrome
2025 · Anne Hubben, Jenna Brown, et al. · Research and Practice in Thrombosis and Haemostasis
PDF
Coastal Workforce Development Success: The U.S. Coastal Research Program & the Keystone Variable Concept
2025 · Bianca Charbonneau, Mary Cialone, et al. · Environmental Challenges
Relapse Free Survival Progressive Shortens in a Subset of Black patients with Immune TTP Treated in the Rituximab Era
2024 · Gangaraju, Radhika, Masias, Camila, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
More Than ADAMTS13: The Impact of Area Deprivation on Major Adverse Cardiovascular Events in Ittp Survivors
2024 · Senthil Sukumar, Jenna Brown, et al. · Blood
PDF
Consequences of unmet pregnancy-specific health care needs in women with immune TTP
2024 · Jenna Brown, Clare Martin, et al. · Blood Vessels Thrombosis & Hemostasis
Response Duration and Relapse Free Survival Shorten after Each Episode of Immune Thrombotic Thrombocytopenic Purpura (iTTP) Treated in the Rituximab Era
2023 · Ayotola Fatola, Marshall Mazepa, et al. · Blood
Works count: 21
Citation count: 74
H-index: 4
I10-index: 3
Year
Topic
Type